MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Detecting clinical fluctuations in chronic biomarker recordings: experiences with chronic subthalamic peak beta band recordings in a large Parkinson’s disease patient cohort

    LK. Feldmann, J. Habets, V. D'Onofrio, V. Mathiopoulou, J. Busch, K. Faust, GH. Schneider, D. Gruber, G. Ebersbacher, AA. Kühn (Berlin, Germany)

    Objective: Since the understanding of electrophysiological biomarker dynamics during every-day activities is crucial for adaptive deep brain stimulation (aDBS), this study aims to investigate characteristics…
  • 2023 International Congress

    Subjective cognitive decline as predictor of objective cognitive decline in Parkinson’s patients

    T. Blum, H. Wurp, S. Wolfsgruber, M. Wagner, L. Consortium, R. Dodel (Essen, Germany)

    Objective: The present study cross-sectionally and longitudinally explores the predictive value of subjective cognitive decline (SCD) regarding objective cognitive decline in a large clinical sample…
  • 2023 International Congress

    Action- and emotion-related language abilities in Slovenian-speaking individuals with Parkinson’s disease – a background normative study

    ž. Drakulić Gorše, C. Manouilidou, M. Trošt (Ljubljana, Slovenia)

    Objective: To prepare action-related (AR) and emotion-related (ER) linguistic stimuli in Slovenian language to test language functions in Parkinson's disease (PD) patients. Background: PD patients…
  • 2023 International Congress

    RNA editing contributes to the inflammatory astrocytic response in Parkinson’s disease.

    A. Wagen, K. D'Sa, M. Choi, S. Strohbuecker, G. Young, R. Reynolds, S. Garcia-Ruiz, Z. Chen, A. Ghareeb, J. Bayne, S. Rodriques, M. Horrocks, S. Gandhi, M. Ryten (London, United Kingdom)

    Objective: 1) Using an IPSC derived cell model to explore astrocytic responses alone and cocultured neurons to alpha-synuclein oligomer (αsynO) treatment.2) Determine the extent to…
  • 2023 International Congress

    Combination of clinical and gait measures to classify fallers and non-fallers in Parkinson’s disease

    H. Araújo, S. Smaili, J. Das, R. Morris, S. Stuart, R. Vitorio (Londrina, Brazil)

    Objective: To identify clinical and objective gait measures that best discriminate fallers from non-fallers in Parkinson’s disease (PD), with suggestions of optimal cutoff scores Background:…
  • 2023 International Congress

    Longitudinal CSF measurements of alpha-synuclein, amyloid beta and tau in Parkinson disease

    R. Miller, A. Li, M. Campbel, J. Perlmutter, P. Kotzbauer (St. Louis, USA)

    Objective: To evaluate whether cerebrospinal fluid (CSF) levels of alpha synuclein (Asyn), amyloid beta (Aβ) and tau change with disease progression and to evaluate whether…
  • 2023 International Congress

    Exercise and levodopa metabolism in Parkinson disease

    M. Figura, J. Giebułtowicz, A. Mrozowicz, S. Szlufik, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our paper was to assess if standard physical exercise may change pharmacokinetics of levodopa/benserazide in patients with and without prior exposure…
  • 2023 International Congress

    Screening risk of falls in Parkinson’s disease population living in underserved areas

    T. Capato, J. Miranda, F. Santos, R. Cury, E. Barbosa (São Paulo, Brazil)

    Objective: To verify the feasibility of the Balance-App to assess the risk of falls in the PD population living in underserved areas. Background: The screening…
  • 2023 International Congress

    The prevalence and clinical features of GBA-related Parkinson’s disease in a Slovak patient cohort

    A. Lackova, J. Necpal, V. Han, P. Pavelekova, K. Kulcsarova, T. Svorenova, L. Baranova, E. Tusay, B. Kovacova, E. Petro, B. Stasko, K. Burasova, M. Ostrozovicova, S. Bohacova, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of our study was to determine the prevalence and clinical characteristics of Slovak GBA-related patients with Parkinson's disease (PwP). Background: GBA variants…
  • 2023 International Congress

    A comparison of national data on Parkinson’s disease mortality between the USA and UK

    N. Smati, W. Lintiso, E. Shamim (Gaithersburg, USA)

    Objective: To evaluate recent mortality trends in Parkinson’s Disease (PD) between the United States of America (USA) and the United Kingdom (UK) per national healthcare…
  • « Previous Page
  • 1
  • …
  • 226
  • 227
  • 228
  • 229
  • 230
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley